Title:
ALBUMIN FUSION PROTEINS
Document Type and Number:
WIPO Patent Application WO2001079444
Kind Code:
A3
Abstract:
The present invention encompasses albumin fusion proteins. Nucleic acid molecules encoding the albumin fusion proteins of the invention are also encompassed by the invention, as are vectors containing these nucleic acids, host cells transformed with these nucleic acids vectors, and methods of making the albumin fusion proteins of the invention and using these nucleic acids, vectors, and/or host cells. Additionally the present invention encompasses pharmaceutical compositions comprising albumin fusion proteins and methods of treating, preventing, or ameliorating diseases, disorders or conditions using albumin fusion proteins of the invention.
More Like This:
WO/1987/005629 | PLANT CELLS RESISTANT TO GLUTAMINE-SYNTHETASE INHIBITORS, MADE BY GENETIC ENGINEERING |
JP2012531885 | IL6 immunotherapeutic agent |
WO/2014/021339 | MONOCLONAL ANTIBODY AGAINST HUMAN MIDKINE |
Inventors:
ROSEN CRAIG A (US)
HASELTINE WILLIAM A (US)
HASELTINE WILLIAM A (US)
Application Number:
PCT/US2001/012013
Publication Date:
May 23, 2002
Filing Date:
April 12, 2001
Export Citation:
Assignee:
HUMAN GENOME SCIENCES INC (US)
ROSEN CRAIG A (US)
HASELTINE WILLIAM A (US)
ROSEN CRAIG A (US)
HASELTINE WILLIAM A (US)
International Classes:
C12N15/09; A61K35/12; A61K35/76; A61K38/00; A61K38/21; A61K38/22; A61K38/23; A61K38/27; A61K38/28; A61K38/43; A61K38/46; A61K38/48; A61K38/55; A61K39/395; A61K47/48; A61K48/00; A61P1/00; A61P1/04; A61P1/16; A61P1/18; A61P3/10; A61P3/14; A61P5/00; A61P5/10; A61P5/14; A61P5/40; A61P7/00; A61P7/04; A61P7/06; A61P9/00; A61P9/06; A61P9/10; A61P9/12; A61P11/00; A61P11/06; A61P13/00; A61P13/02; A61P13/08; A61P13/12; A61P15/00; A61P15/08; A61P15/10; A61P15/18; A61P17/00; A61P17/02; A61P17/06; A61P17/12; A61P17/14; A61P19/00; A61P19/02; A61P19/08; A61P19/10; A61P21/00; A61P21/04; A61P25/00; A61P25/02; A61P25/08; A61P25/16; A61P25/28; A61P27/02; A61P29/00; A61P31/00; A61P31/12; A61P31/14; A61P31/16; A61P31/18; A61P31/20; A61P31/22; A61P33/02; A61P33/06; A61P33/12; A61P35/00; A61P35/02; A61P35/04; A61P37/00; A61P37/02; A61P37/04; A61P37/06; A61P37/08; A61P39/02; A61P41/00; A61P43/00; C07K14/47; C07K14/55; C07K14/56; C07K14/565; C07K14/585; C07K14/60; C07K14/61; C07K14/62; C07K14/635; C07K14/65; C07K14/705; C07K14/715; C07K14/745; C07K14/75; C07K14/76; C07K14/765; C07K14/81; C07K16/00; C07K19/00; C12N1/15; C12N1/19; C12N1/21; C12N5/02; C12N5/10; C12N9/14; C12N9/74; C12N9/99; C12N15/62; A61K39/00; (IPC1-7): A61K39/395; A61K39/00; A61K38/00; C07K1/00
Domestic Patent References:
WO1990013653A1 | 1990-11-15 |
Foreign References:
US5948428A | 1999-09-07 |
Other References:
See also references of EP 1278544A4
Download PDF:
Previous Patent: ALBUMIN FUSION PROTEINS
Next Patent: PLURIPOTENT CELLS COMPRISING ALLOGENIC NUCLEUS AND MITOCHONDRIA
Next Patent: PLURIPOTENT CELLS COMPRISING ALLOGENIC NUCLEUS AND MITOCHONDRIA